Jiangnan University

Huizi Tan

Hao Zhang

Gang Wang

Jianxin Zhao

Qixiao Zhai

Fengwei Tian

Wenwei Lu

The disclosure disclosesfor relieving endotoxin infection and application thereof, and belongs to the technical field of microorganisms. TheCCFM1020 of the disclosure has low immunogenicity, and can reduce the content of pro-inflammatory factors and increase the concentration of anti-inflammatory factors in the blood of hosts infected with endotoxin, up-regulate the number of Foxp3regulatory T cells and stabilize the composition of the intestinal microbiota. A pharmaceutical composition of theCCFM1020 for relieving endotoxin infection has broad application prospects.

for relieving endotoxin infection and application thereof

The disclosure disclosesfor relieving endotoxin infection and application thereof, and belongs to the technical field of microorganisms. TheCCFM1021 of the disclosure has low immunogenicity, and can reduce the content of pro-inflammatory factors and increase the concentration of anti-inflammatory factors in the blood of mice infected with endotoxin, up-regulate the number of Foxp3regulatory T cells and stabilize the composition of the intestinal microbiota. A pharmaceutical composition of theCCFM1021 for relieving endotoxin infection has broad application prospects.

[object Object]

Growing community of inventors

Wuxi, China

Huizi Tan